Profile
Martin Bott served as the VP-Corporate Finance & Investment Banking at Eli Lilly & Co. from 2015 to 2017.
He also served as an Independent Director at InMed Pharmaceuticals, Inc. from 2017 to 2019 and as a Director at CoLucid Pharmaceuticals, Inc. Additionally, he received an undergraduate degree from Universität zu Köln in 1985 and a graduate degree from the University of South Carolina in 1988.
Former positions of Martin Bott
| Companies | Position | End |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Director/Board Member | 2019-08-30 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2017-11-30 |
| COLUCID PHARMACEUTICALS INC | Director/Board Member | - |
Training of Martin Bott
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Martin Bott
















